Siris Capital completes $1.7B acquisition of EFI

PrintAction Staff
July 23, 2019
By PrintAction Staff
Bill Muir, EFI CEO
Bill Muir, EFI CEO
Electronics For Imaging (EFI) today announced the completion of its previously announced acquisition by an affiliate of Siris for approximately US$1.7 billion.

In connection with the closing of the transaction, the company, which will continue to operate as EFI, will be wholly owned by an affiliate of Siris, and EFI’s common shares will be delisted from the NASDAQ exchange.
“This acquisition marks a new, exciting path forward in EFI’s 30-year history as a digital imaging technology leader,” says EFI CEO Bill Muir. “With Siris’ partnership, we will look to create new opportunities for our customers, partners, and EFI employees worldwide. We are looking forward to working with Siris to write the next chapter of innovation across our growing portfolio of solutions.”
“EFI’s portfolio of best-in-class solutions presents an exciting opportunity to drive further growth in high-quality inkjet and integrated, digital workflows. I look forward to working closely with management and know Siris is committed to providing the guidance and support needed to help EFI continue accelerating the transformation of industries where colourful images matter,” Jeff Jacobson, Siris Executive Partner and EFI Executive Chairman, adds.
The transaction, which was initially announced on April 15, was approved in a shareholder vote on July 15, in which 72.2 percent of EFI’s outstanding shares and 99.7 percent of voted shares were voted in favour of the transaction.

Add comment

Security code

Subscription Centre

New Subscription
Already a Subscriber
Customer Service
View Digital Magazine Renew

Most Popular

Latest Events

Printing United 19
October 23-25, 2019
drupa 2020
June 16-26, 2020
Labelexpo Americas 2020
September 15-17, 2020


We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.